Month: January 2024

Medical pendant market Size Worth USD 719.8 Million in 2032 | Emergen Research

Written by Customer Service on January 31, 2024. Posted in Mergers And Acquisitions.

Rising prevalence of chronic diseases and Research & Development (R&D) investments and rising number of healthcare professionals, and technological advancements in medical pendants are key factors driving medical pendant market revenue growth Vancouver, Jan. 31, 2024 (GLOBE NEWSWIRE) — The global medical pendant market size was USD 399.1 Million in 2022 and is expected to register a rapid revenue CAGR of 6.1% during the forecast period. Rising prevalence of chronic diseases and Research & Development (R&D) investments and rising number of healthcare professionals, clinics, hospitals, and other healthcare centers globally, and technological advancements in medical pendants are key factors driving market revenue growth. Medical pendant is designed to economize ward space by keeping equipment clean and elevating...

Aircraft Interface Device Market Size Worth USD 492.9 Million in 2032 | Emergen Research

Written by Customer Service on January 31, 2024. Posted in Mergers And Acquisitions.

Increasing number of Urban Air Mobility (UAM) platforms is a major factor driving aircraft interface device Aircraft Interface Device (AIDs) market revenue growth Vancouver, Jan. 31, 2024 (GLOBE NEWSWIRE) — The global aircraft interface device market size was USD 197.3 Million in 2022 and is expected to register a revenue CAGR of 9.6% during the forecast period. Market revenue growth is driven by major factors such as rising demand for real-time aviation analytics from various industries including commercial, business, and military aircraft, among others, growing number of air-traffic accidents, and increasing need to enhance customer experience. Electronic Flight Bags (EFBs) have gained significant global popularity as operators across the globe have been replacing traditional paper charts and folders with computer screens and...

Video games market Size Worth USD 752.86 Billion in 2032 | Emergen Research

Written by Customer Service on January 31, 2024. Posted in Mergers And Acquisitions.

Increasing penetration of smart devices, rapid advancements in Augmented Reality (AR), Virtual Reality (VR), and rising number of virtual gaming competitions around the world are major factors driving Video games market revenue growth Vancouver, Jan. 31, 2024 (GLOBE NEWSWIRE) — The global video games market size was USD 221.30 Billion in 2022 and is expected to register a rapid revenue CAGR of 13.0% during the forecast period. Increasing penetration of smart devices, rapid advancements in Augmented Reality (AR), Virtual Reality (VR) , and metaverse technology, and rising number of virtual gaming competitions around the world are major factors driving market revenue growth. The global video games market size was USD 221.30 Billion in 2022 and is expected to register a rapid revenue CAGR of 13.0% during the forecast period. Increasing...

Membrane chromatography Market Size Worth USD 1,611.9 Million in 2032 | Emergen Research

Written by Customer Service on January 31, 2024. Posted in Mergers And Acquisitions.

Rising regulatory compliance for purification process and safety and hygiene and increasing automation and user-friendly designs and use of membrane chromatography systems in the biopharmaceutical sector are key factors driving Membrane chromatography Market revenue growth Vancouver, Jan. 31, 2024 (GLOBE NEWSWIRE) — The global membrane chromatography market size was USD 320.0 Million in 2022 and is expected to register a rapid revenue CAGR of 17.6% during the forecast period. Rising regulatory compliance for purification process and safety and hygiene and increasing automation and user-friendly designs of membrane chromatography systems and use of membrane chromatography systems in the biopharmaceutical sector are key factors driving market revenue growth. Moreover, rising investments in Research & Development (R&D)...

Pharmaceutical Quality Control Market Size Worth USD 6.21 Billion in 2032 | Emergen Research

Written by Customer Service on January 31, 2024. Posted in Mergers And Acquisitions.

Rising focus on safety of patients and demand for generic drugs and authenticity of products and implementation of advanced technologies and automation are key factors driving Pharmaceutical Quality Control Market revenue growth Vancouver, Jan. 31, 2024 (GLOBE NEWSWIRE) — The global pharmaceutical quality control market size was USD 2.28 Billion in 2022 and is expected to register a rapid revenue CAGR of 10.6% during the forecast period. Rising focus on safety of patients and demand for generic drugs and authenticity of products, increasing stringent regulatory requirements, and implementation of advanced technologies and automation are key factors driving market revenue growth. Rising prevalence of chronic illnesses is resulting in the need for effective and safe pharmaceutical control solutions. Demand for these pharmaceuticals...

Protein Therapeutics Market Size Worth USD 315.25 Billion in 2032 | Emergen Research

Written by Customer Service on January 31, 2024. Posted in Mergers And Acquisitions.

Rising demand for targeted treatments, rapid advancements in biotechnology and genetic engineering, and increasing Research & Development (R&D) initiatives are key factors driving Protein Therapeutics Market revenue growth Vancouver, Jan. 31, 2024 (GLOBE NEWSWIRE) — The global protein therapeutics market size was USD 152.28 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.6% during the forecast period. Rising demand for targeted treatments, rapid advancements in biotechnology and genetic engineering, and increasing Research & Development (R&D) initiatives are key factors driving market revenue growth. Protein therapies are increasingly utilized to address a spectrum of illnesses and conditions, including cancer, autoimmune diseases, infectious infections, and genetic abnormalities. For example,...

Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Written by Customer Service on January 31, 2024. Posted in Public Companies.

FLORHAM PARK, N.J., Jan. 31, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Wednesday, February 7, 2024, at 1:30 p.m. ET. Company management will also participate in one-on-one meetings during the conference, which will run from February 7-8, 2024. To access the live webcast and an archived recording of the event, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. Recordings will be available for 90 days following the conclusion of the meeting. About...

Arcutis to Present at the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference

Written by Customer Service on January 31, 2024. Posted in Public Companies.

WESTLAKE VILLAGE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference. Details for the company’s participation are as follows: Fireside Chat Date: Wednesday, February 7, 2024Fireside Chat Time: 10:00 am ET The webcast for this conference may be accessed at the “Events” section of the Company’s website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. About ArcutisArcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a commercial-stage medical dermatology company that champions meaningful innovation to address...

Constellium to Report Fourth Quarter and Full Year 2023 Results on February 21, 2024

Written by Customer Service on January 31, 2024. Posted in Public Companies.

PARIS, Jan. 31, 2024 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) will host a conference call and webcast on Wednesday, February 21, 2024, at 10:00 AM (Eastern Time) to announce its fourth quarter and full year 2023 results. The press release will be sent before market opening. The conference call will be hosted by Jean-Marc Germain, Chief Executive Officer, and Jack Guo, Senior Vice President and Chief Financial Officer. Details of the conference call, webcast and accompanying presentation will be available on the Constellium Investor Relations page at: https://www.constellium.com/investors/financial-results The webcast can be accessed live at: https://events.q4inc.com/attendee/791811898. To participate by telephone, please dial the following number and enter access code 422810 to be connected to the Constellium earnings call:United...

Merus to Participate in Upcoming Investor Conferences

Written by Customer Service on January 31, 2024. Posted in Public Companies.

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in a fireside chat at the following investor conferences:Guggenheim 6th Annual Biotechnology Conference: Wednesday, February 7, 2024 at 2:30 p.m. ET Citi’s 2024 Oncology Leadership Summit: Thursday, February 22, 2024 at 9:00 a.m. ETThe webcasts of the presentations will be contemporaneously available on the Investors page of the Company’s website. Archived presentations will also be available there for a limited time after the event. About MerusMerus is a clinical-stage oncology company developing...

Month: January 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals